Refine
Is part of the Bibliography
- yes (56)
Year of publication
Document Type
- Jahresbericht (51)
- Report (5)
Keywords
- Bericht (56) (remove)
Institute
Sonstige beteiligte Institutionen
Besides their central role in haemostasis and thrombosis, platelets are increasingly recognised as versatile effector cells in inflammation, the innate and adaptive immune response, extracellular matrix reorganisation and fibrosis, maintenance of barrier and organ integrity, and host response to pathogens. These platelet functions, referred to as thrombo-inflammation and immunothrombosis, have gained major attention in the COVID-19 pandemic, where patients develop an inflammatory disease state with severe and life-threatening thromboembolic complications. In the CRC/TR 240, a highly interdisciplinary team of basic, translational and clinical scientists explored these emerging roles of platelets with the aim to develop novel treatment concepts for cardiovascular disorders and beyond. We have i) unravelled mechanisms leading to life-threatening thromboembolic complica-tions following vaccination against SARS-CoV-2 with adenoviral vector-based vaccines, ii) identified unrecognised functions of platelet receptors and their regulation, offering new potential targets for pharmacological intervention and iii) developed new methodology to study the biology of megakar-yocytes (MKs), the precursor cells of platelets in the bone marrow, which lay the foundation for the modulation of platelet biogenesis and function. The projects of the CRC/TR 240 built on the unique expertise of our research network and focussed on the following complementary fields: (A) Cell bi-ology of megakaryocytes and platelets and (B) Platelets as regulators and effectors in disease. To achieve this aim, we followed a comprehensive approach starting out from in vitro systems and animal models to clinical research with large prospective patient cohorts and data-/biobanking. Despite the comparably short funding period the CRC/TR 240 discovered basic new mechanisms of platelet biogenesis, signal transduction and effector function and identified potential MK/platelet-specific molecular targets for diagnosis and therapy of thrombotic, haemorrhagic and thrombo-inflammatory disease states.
Jahresbericht 2018/2020
(2021)
Jahresbericht 2016/2017
(2018)
Jahresbericht 2016/2017
(2018)
Jahresbericht 2014/2015
(2017)
Jahresbericht 2012/2013
(2017)
Jahresbericht 2011
(2012)
Jahresbericht 2009/2010
(2011)
Jahresbericht 2007/2008
(2011)
Jahresbericht 2005/2006
(2010)
No abstract available
Jahresbericht 1999
(2000)
Jahresbericht 1998
(1999)
Jahresbericht 1997
(1998)
Jahresbericht 1996
(1997)
Jahresbericht 1995
(1996)
Jahresbericht 1994
(1995)
Jahresbericht 1993
(1994)
Jahresbericht 1992
(1993)
Jahresbericht 1991
(1992)
Jahresbericht 1990
(1991)
Jahresbericht 1989
(1990)
Jahresbericht 1988
(1989)
Jahresbericht 1987
(1988)
Jahresbericht 1986
(1987)
Jahresbericht 1985
(1986)
Jahresbericht 1984
(1985)
Jahresbericht 1983
(1984)
Jahresbericht 1982
(1983)
Jahresbericht 1981
(1982)
Jahresbericht 1980
(1981)
Jahresbericht 1979
(1980)
Jahresbericht 1978
(1979)
Jahresbericht 1977
(1978)